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ABSTRACT
The trip to Mars and back is planned for the next 20 years. Improvement in technology and
research has allowed data analysis, at a larger scale, on spaceflight specimen. However,
research involving spaceflight is decentralized, as research is spread across laboratories with
different methodologies. NASA’S GeneLab is a public repository for spaceflight-related omics
data and promotes centralizing spaceflight RNA-Seq studies using NASA’s RNA-Seq pipeline.
Jonathan Oribello, a SJSU’s Bioinformatics graduate and now an employee at GeneLab, has
implemented Nextflow to NASA’s RNA-Seq pipeline. The Nextflow RNA-Seq pipeline was ran on
San Jose State University’s College of Science High Performance Computing system, using study
GLDS-103 from GeneLab. The results have shown the reproducibility of Nextflow, and new
insights through customizable inputs. This project has shown possible insights to the skeletal
muscle system, and the effects of microgravity on the circadian rhythm.
Keywords: Skeletal Muscle, Circadian Rhythm, Microgravity, Nextflow
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I. INTRODUCTION
A. Spaceflight Endeavors
Exploring outer space is an endeavor for humankind. In 2017, President Trump issued a
memorandum called “White House Space Policy Directive-1” [1]. This directive sets goals for
humanity’s return to the Moon in 2024: to establish payloads on the surface, to assemble a
Gateway outpost in orbit, and demonstrate the first lunar landing since 1972 [2]. In response to
the directive, The National Aeronautics and Space Administration (NASA) created the Artemis
Program that has two phases [3]. Phase 1 details the return to the Moon by landing the first
woman and man at the lunar South Pole by 2024, and setting up two Gateway components, the
Power and Propulsion Element (PPE), and the Habitation and Logistics Outpost (HALO), both
launching in 2022 and 2023 respectively. Phase 2 advances technology for sustainability during
space exploration—allowing for longer missions. Due to the COVID pandemic, NASA is expecting
delays up to several years from the planned 2024 year [4]. Even with the projected delay, the
excitement of new technology and research is never ending.
Taking humans to Mars and beyond has been in the scope for years and is planned for the
next 20 years [5]. The trip to Mars and back would take several years, with hazards such as
radiation, isolation, microgravity, confinement, and nutrition being concerns during longduration space missions [6]. Two hazards, space radiation and microgravity, are heavily studied
and are the two primary hazards preventing long-duration spaceflights [7]. Radiobiological
research link exposure to radiation to growth of cancer, dysfunctional central nervous system,
and break down of tissues [8]. Exposure to microgravity is known to affect cardiovascular,
musculoskeletal, bone metabolic, and immune systems [9]. Understanding these hazards will
provide solutions for astronauts during their trip to Mars and other long-duration spaceflights.
With the rapid advancement of omics technologies, opens to higher volume of data analysis on
spaceflight specimens. NASA’s Rodent Research (RR) aims to provide a better understanding of
these hazards and offer solutions to counteract the negative effects [10]. In this project, data
taken from NASA’s RR will be approached statistically differently, with the intent to provide
more exploration and discoveries regarding microgravity and skeletal muscle.
B. Skeletal Muscle: a Brief Review
Skeletal muscle is a type of striated muscle which is composed of cells that require high
energy [11]. This muscle type is the main driving force of contraction and movement. As
depicted in Figure 1, skeletal muscle is an organized tissue, with bundles called muscle fibers
(myofibers) that form bundles of fascicles, that of which form the muscle tissue. Myofibers are
made of sarcomeres, units that make up the myofibers. Contraction of sarcomeres are
important for force generation and rapid movement. The repeating units of sarcomeres are
composed of actin and myosin and during contraction, Ca2+ is released from the sarcoplasmic
reticulum—activating the actin-myosin cross bridging and contraction [12]. Skeletal muscle is
8

important for efficient energy production and cellular homeostasis, two processes that are part
of metabolic and regulatory systems. Disruptions, by genetic or environmental factors, to the
skeletal tissue results in lower muscle health and function (caused by muscle fiber loss) and
probable death.

Figure 1: A single mature muscle fiber, shown as a bundle of myofibrils, encased by the sarcolemma from [11].

C. Studies Related to Spaceflight and Skeletal Muscle
The musculoskeletal system in relation to spaceflight have shown to produce many
consequences. Microgravity decreases muscle mass, force, and shifts the muscle fiber type to a
swifter contracting but less durable phenotype [13], [14]. In detail, inactive skeletal muscle
during microgravity induce atrophy while active skeletal muscle during microgravity undergo
hypertrophy [15], [16]. On average, 20% of inactive skeletal muscle mass is lost under normal
conditions while 30%, on average, of skeletal muscle mass is lost under microgravity [17]. This
loss of skeletal muscle mass is enough to hinder astronauts, preventing spacewalks, and doing
repairs on the International Space Station (ISS). Therefore, studying the cellular and molecular
mechanisms of skeletal muscle atrophy caused by microgravity will provide new ways to
counteract the negative effects of microgravity. One new way to study the effects of
microgravity on skeletal muscle is associating both bone and skeletal muscle systems [18].
9

These studies involving both bone and skeletal muscle tissue will allow full comprehension of
the negative effects of microgravity. Therefore, this project will seek out biological processes
involved in either bone or skeletal muscle tissue.
In vitro studies have shown that microgravity directly affects skeletal muscle cell
differentiation and metabolism, allowing skeletal muscle cells to be potential countermeasure
targets [16], [19], [20]. Additionally, studies involving Ca2+ signaling suggest that improper
signaling of Ca2+ ions in skeletal muscle tissue leads to lower activity of myogenesis and
skeletal muscle metabolism [21], [22]. For in vivo studies, astronauts exposed by microgravity
have shown loss skeletal muscle mass and strength, mainly in areas from the hip to the toes
and the torso [12]. Furthermore, in 6-9 days under microgravity conditions, skeletal muscle loss
occurred rapidly in the quadriceps, gastrocnemius, and posterior back muscle, with values of
6%, 6%, and 10% respectively [23]–[25]. Longer duration missions of 6 months resulted to even
greater muscle loss, with values of 12%, 13%, and 20% for the quadriceps, soleusgastrocnemius, and posterior back skeletal muscles respectively [25]–[27]. The data suggests
that muscle loss stabilizes after 3-4 months of exposure to microgravity and this loss is because
of lower protein synthesis than degradation of the skeletal muscle tissue [25], [28]. Both in vitro
and in vivo studies have shown substantial evidence of skeletal muscle loss and possible ways
to alleviate microgravity conditions for both short and long duration missions. Further
investigation into proteins and biological processes related to skeletal muscle tissue will open
for more possibilities.
D. NASA’s GeneLab and RNA-Seq Pipeline
NASA’s GeneLab is a public database of space related studies and its goal is to collect data
from biospecimens in both space and simulated space stressor conditions, while providing
access to omics data [29]. GeneLab currently has 340 studies and are accessible through the
home page https://genelab.nasa.gov/ [30]. NASA plans to centralize RNA-Seq data by
minimizing variations through its RNA-Seq consensus pipeline (RCP). It is reasonable for NASA
to encourage RNA-Seq data to follow a consensus pipeline since different software tools
produce different results [31]–[33]. As depicted in Figure 2, RCP is split into three parts: Data
Preprocessing, Data Processing, and Differential Gene Expression Calculation. A recent San Jose
State University (SJSU) Bioinformatics graduate, Jonathan Oribello, has taken NASA’s RCP and
implemented Nextflow, a workflow management system that allows for reproducibility [34].
Jonathan now works with NASA’s GeneLab and has continued to work on RCP with Nextflow for
reproducibility. The software is hosted on GitHub and is found at https://github.com/J81/Nextflow_RCP [35]. The Nextflow RCP (NRCP) was used for data processing in this project.
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Figure 2: NASA’s consensus RNA-Seq pipeline from [28]

E. GLDS-103
The study of interest, GLDS-103, was taken from GeneLab and a part of NASA’s RR project
[36]. 12 mice of similar age, sex, and strain were used in study GLDS-103, where 6 of the mice
were sent to the ISS and exposed to microgravity for 37 days. The other 6 were used for ground
control and had matching ISS environmental conditions. Mice flown to the ISS were the
experimental control group of this study, and are labeled as FLT, while ground control mice are
labeled as GC, the control group of the study. FLT mice had their tissues extracted, with the left
quadriceps muscle as the main muscle of study and transported back to Earth. The construction
of the RNA library was done at UC Davis Genome Center, using Illumina TruSeq standard RNA
library prep kit. The Illumina HiSeq 4000 platform was used on the RNA library, with 30 million
reads per sample and sequenced by paired end 150 bp reads. The resulting raw data files are
hosted under GLDS-103’s repository and are used in this project.
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II. METHODS
A. Running the Nextflow RCP
NRCP was run on SJSU’s College of Science (CoS) High Performance Computing (HPC) system,
ideal for large data processing due to its large data storage of 110 TB. SJSU’s CoS HPC system
uses a resource scheduling program called SLURM, allowing users to submit batch jobs [37]. In
In Appendix: Scripts, Script 1 was used in this project for HPC. NRCP was ran on July 15th, 2021,
of which the version of NRCP was last committed on July 11, 2021. Since the date of which
NRCP was ran on for this project, several commits were done, with the last commit done on
October 4, 2021. Figure 3 shows the publicly available NRCP and its contents on GitHub. The
bin folder contains scripts that runs the various tools used throughout the pipeline, of which
data preprocessing and data processing are written in Python and differential gene expression
calculation is written in R [38], [39].

Figure 3: GitHub repository for NRCP under the user J-81 (Jonathan Oribello)

1) Nextflow
In previous SJSU Bioinformatics Master projects, a configuration file was needed to run
Nextflow on CoS-HPC in order to properly extract data [40]–[42]. However, as of July 15, 2021, a
configuration file is no longer needed. NRCP automatically retrieves necessary data found in
GeneLab and ENSEMBL [43]. Version GRCM39 for the genome file and annotation file were used
for reference assembly. Running NRCP requires a Linux environment with Nextflow and Conda
installed. Connecting to the CoS-HPC requires access through a SSH client and a VPN. PuTTY
12

version 0.74, a SSH client, and Cisco AnyConnect Secure Mobility Client version 4.10.03104, a
VPN, were both used to connect to the CoS-HPC [44], [45]. Script 1 was submitted as a job on
CoS-HPC, with lines 13 and 14 tokenizing the job for Nextflow Tower and line 16 running NRCP.
Nextflow Tower allows the user to observe the current state of the job and current processes
that are running as shown in Figure 4. Other stats, such as run time and total memory, are also
available on Nextflow Tower.

Figure 4: (A) Status panel from Nextflow Tower (B) Processes Panel from Nextflow Tower

2) Data Preprocessing
Data preprocessing is part of the first step of the NRCP pipeline, where raw RNA sequence
data is checked for quality. Additionally, the raw RNA sequence data will be trimmed—filtering
bad reads along with adaptor removal. FastQC version 0.11.9 quality control checks the raw
FASTQ files from GLDS-103 [46]. MultiQC version 1.7 compiles the FastQC logs to allow better
visualization of all raw FASTQ files [47]. Trim Galore version 0.6.6 and Cutadapt version 2.6
filters out bad reads (Phred scores under 20) and trims out adaptors from Illumina TruSeq [48].
The NRCP can identify between single and paired end reads and because paired end reads were
used, both Trim Galore and Cutadapt have trimmed the data accordingly.
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3) Data Processing
Data processing is the second step of the NRCP. STAR version 2.7.9a is a tool that aligns
the trimmed reads from step 1 to the reference genome but requires the reference FASTA file
and GTF file [49]. The necessary files were obtained from ENSEMBL version 104 [43]. After the
reference genome has been indexed, using the files from ENSEMBL, the trimmed reads can now
be mapped. RSEM version 1.3.1 was used to quantify the number of reads mapped to each
annotated transcript and gene [50]. After RSEM has finished quantifying the samples, a
unnormalized counts table is produced, containing the 12 samples and genes that were found.
MultiQC version 1.7 was used to compile the log files produced from STAR alignment results.
4) Differential Gene Expression Calculation
The final step in pipeline is where differential gene expression (DGE) is calculated. The bin
folder contains the R script file, _normcounts_noERCC_DGE_vis_ISA.R, which runs the
DeSEQ2 version 1.30 R package on R version 4.0.3 [39], [51]. The R script file creates a
DESeqDataSet object, which will be manipulated later in the script. Before DESeq2 is run on the
RSEM count data, all genes with a sum of less than 10 counts from all samples are removed.
When running DESeq2 after filtering out genes, three functions are called in this order on the
DESeqDataSet object, estimateSizeFactors(), estimateDispersions(), and
nbionmWaldTest().
estimateSizeFactors() estimates the size factors using a median ratio method,
and a size factor is created for every sample by dividing the median ratio of all counts by the
mean of the genes from all samples.
estimateDispersions() takes dispersion estimates of the data by using a negative
binomial distribution (DESeq2 also assumes that the data follows a negative binomial
distribution, thus the usage of the function). The dispersion per gene is found optimizing the
Cox-Reid adjusted profile likelihood [51]. The dispersion parameter is the relationship between
the variance of the observed count and its respective mean value.
Lastly, nbionmWaldTest(), which tests for significance of coefficients by calculated
‘sizeFactors’ and dispersion estimates. Wald Test calculates the statistical significance of a
gene’s expression by producing a p-value. The raw count and normalized data are extracted
into objects and then exported.
Adjusted p-values are also calculated using the Benjamini-Hochberg (BH) method, a
method that accounts for the multiple testing problem by a set FDR value. The FDR value was
0.1, of which the p-values for genes that have passed the filter will be calculated as an adjusted
p-value using the BH method.
5. Mapping gene ID
After DGE calculation is complete, an annotation database is built, of which a “keytype” is
defined, indicating the primary type of annotation. By default, GeneLab uses ENSEMBL as its
14

keytype; therefore, ENSEMBL is then used to map annotations of the organism through
Bioconductor AnnotationDbi version 1.52.0 package. Additional annotation columns from the
package are added to the annotation database: SYMBOL, GENENAME, ENSEMBL, REFSEQ, and
ENTREZID. Other annotation columns such as, STRING, and GOSLIM are also added into the
annotation columns using STRINGDB version 2.2.0 and PANTHERdb version 1.0.10 R packages.
After the annotation database is completed, the means and standard deviations of the
normalized count data for each gene is calculated for all samples, and again but for samples
within each respective group. The final DGE output table is ready to be assembled, combining
all the data together in a .csv file.

B. Gene Set Analysis
To analyze every gene from the DGE table is time consuming, an alternative and powerful
method is to analyze genes in gene sets, or groups of genes that share biological function,
cellular location, or regulation [52]. GSEA and DAVID are tools used to perform gene set
analysis, in which Leading Edge Analysis is another analytical tool in GSEA that can help offer
insight on what genes are prevalent in gene sets.
1) DAVID
DAVID version 6.8 functional annotation clustering was used to analyze genes with
adjusted p-value under 0.05, of which 773 genes were used [53], [54]. The tool generates gene
set clusters based on enriched gene sets that have overlapping significant genes. This allows for
insight into sets of annotations with a common theme.
2) GSEA
Gene set enrichment analysis (GSEA) version 4.1.0 was used to compare the total gene list
produced from NRCP to two gene set collections in MsigDB version 7.4: hallmark and gene
ontology biological processes (GOBP). Hall mark gene sets are excellent as a comparison since
they are well-defined biological states or processes. A subset of the C5 (ontology gene sets)
gene set collection, the GOBP gene sets, will be used as a comparison to explore significant
biological processes. 22,211 genes were produced from NRCP and extracting only the ENSEMBL
identifiers into a .txt file, of which is used as the expression dataset. Because each condition
contains less than 7 samples, and that the experiment is comparing only two conditions, it was
recommended to run the “Permutation type” parameter as gene_set, randomizing the gene set
for each permutation instead of the phenotype label [52]. However, this causes a less stringent
assessment of significance and users would want to use a stringent FDR cutoff such as 0.05 [52].
Due to GLDS-103 using mouse as the model organism,
Mouse_ENSEMBL_Gene_ID_Human_Orthologs_MSigDB.v.7.4.chip was used as the Chip
platform, converting the ENSEMBL gene identifiers to their respective human ortholog. The
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expression data set was then ranked by Signal2Noise, the default ranking method by GSEA, and
was recommended by Anthony Castanza, a member of the MsigDB team, since each group had
more than 3 samples [55]. Figure 5 depicts the Signal2Noise calculation, where μ is the mean
and σ is the standard deviation. σ has a minimum value of 2 times the absolute value of μ and μ
is adjusted to 1 if μ is 0. As the signal-to-noise ratio increases, the difference of means
increases, meaning, the more distinct the gene expression is in each phenotype [52]. The FDR
threshold is less than 0.25 and was used for both runs.

μ𝐴 −μ𝐵
σ𝐴 +σ𝐵
Figure 5: Signal2Noise calculation, where subscript A is phenotype 1 and subscript B is
phenotype 2 from [52]
3) Leading Edge Analysis
Leading Edge Analysis (LEA) was used for the C5 GOBP subset gene set collection, in
comparison to the 22,211 genes. Gene sets with nominal p-values under 0.05 were taken, for a
total of 637 significant gene sets.
4) Visualization of Gene Ontology Biological Processes by Cytoscape’s Enrichment Map
Cytoscape version 3.9.0 was used to create a visualization through the EnrichmentMap
version 3.3.3 app. GSEA allows to automate the inputs for the EnrichmentMap app by using
GSEA’s Enrichment Map Visualization tool. The only parameters needed to create the
enrichment map are p-value, FDR q-value, and overlap coefficients, of which values of 0.05,
0.25, and 0.5 were used and were considered ‘Very permissive’ as stated by the
EnrichmentMap app documentation. Conservative parameters were not used since it is
recommended that 100-250 enriched terms at the very conservative thresholds. The
Enrichment Map Visualization tool with ‘Moderately conservative’ parameters (p-value of 0.005
and FDR value of 0.075) was also ran to showcase the difference between results of the two
parameters. Clusters were then annotated through AutoAnnotate version 1.3.4, using
WordCloud version 3.1.4, and computing annotations based on the scoring of adjacent words
across all the gene set GOBP terms [56], [57].

III. RESULTS
A. Nextflow RNA-Seq Pipeline
1) NRCP run time
Table 1 shows the run time of NRCP, of which two runs were done since run number 1
encountered an error, where the allotted memory to run STAR alignment was too low (STAR
16

alignment requires a minimum of 32 GB of memory); therefore, as shown in Script 1, the
allotted memory for the job was increased to 120 GB and NRCP was able to run into
completion.

TABLE I
STATS OF NRCP
Run number
1
2

Run time
1 h 42 m 8 s
1 d 17 h 40 m 36 s

CPU time (hrs)
15.1
240.0

Total memory (GB)
37.20
465.45

2) Comparison of results from NRCP and NASA
Comparisons of NRCP and NASA was done by taking the expression data set and filtering
genes that have a p-value of less than 0.05. This was done because publications for the Rodent
Research project used p-value of less than 0.05. NRCP had 51 unique genes while NASA had 80
unique genes. This showcase that NRCP almost reproduces identical results.

Figure 5:Venn diagram of genes with a p-value of less than 0.05. Non-overlapping regions are not to scale.

B. Quality Control Metrics
Figure 6 displays the numbers of reads that were present in the raw FASTQ files. It is
expected for RNA-Seq reads to show many duplicate reads. Figure 7 shows both untrimmed
and trimmed reads and are labeled as A and B respectively. The compilation by MultiQC shows
that there is a disparity between pair reads, of which the reverse reads are worse. However,
this is a tendency by reverse reads. The Phred score of the trimmed reads remained above 30,
indicating that the quality across the 150 base pair reads was excellent, with improvement
toward the last few base pairs. There is a reported bias in the first few bases according to
17

FastQC. The cause of this bias is the random priming step in library production, however, the
potential concerns are not problematic [58].

Figure 6: Total Read Counts for Each Sample

Figure 7: MultiQC Mean Quality Score Plots (A) Untrimmed reads (B) Trimmed reads
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C. Alignment Metrics
For STAR alignment (Figure 8), MultiQC reported that at least 78.9% of reads for every
sample (including reverse reads) were uniquely mapped to a location. About 12% of reads for
every sample were mapped to multiple loci (2-10). About 9% of reads for every sample were
unmapped due to alignment lengths being too short. About 0.1% of reads were mapped to too
many loci (over 10 loci) and about 0.2% of reads for every sample were unmapped due to other
reasons.
For RSEM counts (Figure 9), MultiQC reported that at least 77.1% of reads for every sample
were uniquely mapped to a gene. About 10.9% of reads for every sample were mapped to
multiple genes and about 12.1% of reads for every sample were unable to be aligned to genes.
There were no instances of reads being aligned to too many genes for every sample.

Figure 8: Star Alignment Metrics
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Figure 9: RSEM Counting Metrics

D. DESeq2 analytical plots
PCA plots is shown in Figure 10, where (A) is NRCP and (B) is NASA. The PCA plot for NRCP
was made by first taking the log2 of the normalized count data from DESeq2. The function,
prcomp(), takes the log2 data as an input and creates the PCA plot. Looking at the plots, both
plots show identical variation between the two conditions.
The dispersion plot is a useful diagnotic to show outliers in the expression data set [51].
Outliers are found through several parameters. Gene-wise maximum likelihood estimates (MLE)
are obtained using the respective gene data (black dot). A curve is then created (red) to fit the
MLEs and to show the overall dispersion-mean dependence across all the genes. Genes are
then fitted (understood as shrinkage) of which the gene-wise estimates head towards the
consensus line. Black circles encircled by a blue outline are outliers and are not shrunk towards
the consensus line. Figure 11 was created using the function plotDispEsts() and inputting the
object that was saved when DESeq2 is ran on the DESeqDataSet object.
A MA plot was created to show the dispersion of gene expression between the two
condition. It is useful to showcase genes that are upregulated in FLT mice and genes that are
downregulated in FLT mice. Genes that show a positive log2 fold change value of 1 means that
20

the gene is expressed 2 times more in FLT mice than in GC mice and genes that show a negative
log2 fold change value of 1 is twice as under expressed in FLT mice than in GC mice. Points
shaped as triangle are genes that are beyond the plot’s scale. Figure 12 was created using the
plotMA() function and inputting the result object that was created using the results() function.

Figure 10: Principal Component Analysis Plots of (A) NRCP and (B) NASA

Figure 11: Dispersion plot. Black dots represent genes. Black dots encircled in a blue outline are outliers.
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Figure 12: MA Plot, where every point represents a single gene. Points colored blue are significant under the BenjaminiHochberg method (adjusted p-value <0.05)

E. Gene Set Analysis by DAVID and GSEA
1) DAVID Gene Annotation Clusters
The top three enriched DAVID gene annotation clusters are shown in Table II. Annotation
Cluster 1 detail disruptions in biological rhythms, particularly the circadian rhythm and its
rhythmic process. Gene regulation regarding the circadian rhythm is also disrupted. Annotation
Cluster 2 details disruption of transcription regulation. Annotation Cluster 3 show disruptions of
the zinc finger, which the other terms, zinc, and metal-binding, are associated with. Zinc finger
is an interesting term found in adjusted p-value gene list and will be investigated further.
Annotation Cluster 1, Annotation Cluster 2, and Annotation Cluster 3, have an enrichment score
of 8.84, 5.56, and 5.21 respectively.
2) Gene Set Enrichment Analysis
Table III and Table IV are the results from GSEA when comparing all genes to the Hallmark
collection gene set with an FDR threshold of 0.25. Table V depicts the 10 most prevalent genes
from the 637 significant gene sets when comparing all genes to the C5 GOBP subset. Figure 13
showcases the ‘Moderately conservative’ EnrichmentMap results. Figure 14 and 16 showcase
the ‘Very permissive’ results. In total, Figure 14 and 16 displays 188 nodes, 56 of which are not
shown due to the node not connected to another node. However, the 56 nodes that are not
shown does not mean they are insignificant, and exclusion of these nodes are mainly for display
purposes.
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TABLE II
TOP THREE ENRICHED DAVID GENE ANNOTATION CLUSTERS
Category
Annotation Cluster 1
UP_KEYWORDS
GOTERM_BP_DIRECT
KEGG_PATHWAY
GOTERM_BP_DIRECT
GOTERM_BP_DIRECT
GOTERM_BP_DIRECT
Annotation Cluster 2
UP_KEYWORDS
UP_KEYWORDS
UP_KEYWORDS
GOTERM_BP_DIRECT
UP_KEYWORDS
GOTERM_BP_DIRECT
UP_KEYWORDS
GOTERM_MF_DIRECT
GOTERM_MF_DIRECT
Annotation Cluster 3
UP_KEYWORDS
UP_KEYWORDS
GOTERM_MF_DIRECT
GOTERM_MF_DIRECT
UP_KEYWORDS

Term

FDR

Biological rhythms
GO:0007623~circadian rhythm
mmu04710:Circadian rhythm
GO:0048511~rhythmic process
GO:0032922~circadian regulation of gene expression
GO:0042752~regulation of circadian rhythm

1.26E-09
1.07E-07
3.68E-08
1.26E-06
1.52E-05
0.026716

Repressor
Transcription regulation
Transcription
GO:0006351~transcription, DNA-templated
Activator
GO:0006355~regulation of transcription, DNA-templated
DNA-binding
GO:0003677~DNA binding
GO:0003700~transcription factor activity, sequence-specific
DNA binding

9.14E-08
1.28E-07
1.29E-07
4.92E-04
5.48E-05
0.002172
0.010013
0.071981
0.425386

Metal-binding
Zinc
GO:0008270~zinc ion binding
GO:0046872~metal ion binding
Zinc-finger

1.60E-05
2.17E-05
0.002475
0.002475
0.001091
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TABLE III
GSEA UPREGULATED HALLMARK GENE SETS
NAME
HALLMARK_INTERFERON_GAMMA_RESPONSE
HALLMARK_CHOLESTEROL_HOMEOSTASIS
HALLMARK_HEDGEHOG_SIGNALING
HALLMARK_INTERFERON_ALPHA_RESPONSE
HALLMARK_COMPLEMENT
HALLMARK_TNFA_SIGNALING_VIA_NFKB
HALLMARK_COAGULATION
HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITIONN
HALLMARK_MTORC1_SIGNALING
HALLMARK_SPERMATOGENESIS
HALLMARK_MITOTIC_SPINDLE
HALLMARK_ANGIOGENESIS
HALLMARK_HYPOXIA
HALLMARK_APICAL_SURFACE
HALLMARK_KRAS_SIGNALING_DN
HALLMARK_KRAS_SIGNALING_UP
HALLMARK_IL6_JAK_STAT3_SIGNALING
HALLMARK_G2M_CHECKPOINT
HALLMARK_ESTROGEN_RESPONSE_LATE
HALLMARK_IL2_STAT5_SIGNALING
HALLMARK_GLYCOLYSIS
HALLMARK_ANDROGEN_RESPONSE
HALLMARK_ESTROGEN_RESPONSE_EARLY
HALLMARK_PI3K_AKT_MTOR_SIGNALING
HALLMARK_APICAL_JUNCTION
HALLMARK_NOTCH_SIGNALING
HALLMARK_UV_RESPONSE_DN
HALLMARK_E2F_TARGETS
HALLMARK_UV_RESPONSE_UP
HALLMARK_APOPTOSIS
HALLMARK_FATTY_ACID_METABOLISM
HALLMARK_PANCREAS_BETA_CELLS
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ES
0.482672
0.481399
0.547643
0.447914
0.365104
0.35591
0.361799
0.302906
0.297977
0.30926
0.279182
0.37531
0.273634
0.338806
0.268661
0.260746
0.286122
0.24951
0.251591
0.243075
0.238116
0.242173
0.217192
0.232547
0.210236
0.284838
0.21378
0.204165
0.20756
0.199951
0.18256
0.243311

NES
2.187474
1.894577
1.875297
1.835957
1.616055
1.614682
1.523447
1.376175
1.367554
1.289498
1.281991
1.241098
1.239432
1.21013
1.183101
1.179588
1.176885
1.14806
1.133096
1.10955
1.087641
0.987504
0.984076
0.975665
0.955581
0.95034
0.933273
0.931846
0.925569
0.892449
0.798649
0.779823

NOM p-val
0
0
0.001786
0
0.001462
0.001497
0.00315
0.019802
0.024024
0.072214
0.055394
0.172007
0.076135
0.184801
0.151917
0.15188
0.177953
0.181159
0.192956
0.226387
0.277778
0.490291
0.48538
0.499237
0.557833
0.540448
0.606928
0.609442
0.641337
0.721386
0.892128
0.789946

FDR q-val
0
0.002039
0.002016
0.001512
0.016717
0.013931
0.032807
0.128215
0.123942
0.222789
0.215113
0.270664
0.25349
0.297007
0.339317
0.326272
0.313153
0.358497
0.37597
0.412637
0.453047
0.720882
0.700853
0.700114
0.73086
0.718131
0.738535
0.716154
0.70831
0.769917
0.944097
0.941415

TABLE IV
GSEA DOWNREGULATED HALLMARK GENE SETS
NAME
HALLMARK_MYC_TARGETS_V2
HALLMARK_MYC_TARGETS_V1
HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY
HALLMARK_DNA_REPAIR
HALLMARK_UNFOLDED_PROTEIN_RESPONSE
HALLMARK_INFLAMMATORY_RESPONSE
HALLMARK_MYOGENESIS
HALLMARK_XENOBIOTIC_METABOLISM
HALLMARK_HEME_METABOLISM
HALLMARK_P53_PATHWAY
HALLMARK_OXIDATIVE_PHOSPHORYLATION
HALLMARK_BILE_ACID_METABOLISM
HALLMARK_PEROXISOME
HALLMARK_PROTEIN_SECRETION
HALLMARK_ALLOGRAFT_REJECTION
HALLMARK_ADIPOGENESIS
HALLMARK_WNT_BETA_CATENIN_SIGNALING
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ES
-0.4748
-0.36855
-0.41817
-0.30228
-0.29583
-0.27016
-0.2662
-0.26224
-0.2377
-0.23869
-0.22071
-0.2274
-0.21821
-0.21131
-0.17894
-0.15816
-0.21028

NES
-1.91201
-1.8331
-1.6178
-1.43666
-1.32713
-1.32149
-1.30867
-1.26928
-1.17278
-1.15876
-1.08125
-1.00891
-0.98109
-0.92838
-0.86684
-0.78721
-0.75408

NOM p-val
0.002525
0
0.007444
0.005848
0.054496
0.019868
0.020896
0.050562
0.107744
0.132258
0.240356
0.408108
0.479381
0.625337
0.846386
0.977419
0.838863

FDR q-val
0.003985
0.004309
0.015261
0.074423
0.150923
0.129248
0.123763
0.144889
0.268996
0.268841
0.420551
0.607098
0.653097
0.779998
0.89971
0.979796
0.951449

TABLE V
PREVALENT GENES FROM LEADING EDGE ANALYSIS ON 637 GO BP GENE SETS
Gene ID

Description

Expression

WNT5A

Wnt family member 5A

Upregulated

Number of times gene
is in a gene set
108

EDN1

endothelin 1

Upregulated

107

PTK2B

protein tyrosine kinase
2 beta

Upregulated

82

GHRL

ghrelin and obestatin
prepropeptide

Upregulated

77

F2RL1

F2R like trypsin
receptor 1

Upregulated

74

SHH

sonic hedgehog
signaling molecule

Upregulated

72

JAK2

Janus kinase 2

Upregulated

66

ANXA1

annexin A1

Upregulated

64

TLR4

toll like receptor 4

Upregulated

59

NOD2

nucleotide binding
oligomerization
domain containing 2

Upregulated

58
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Figure 13: GO Biological Processes Gene Set Collection Enrichment Map with ‘Moderately conservative’
parameters. Red nodes indicate upregulation and blue nodes indicate downregulation. Connections (edges)
mean overlap of significant genes shared between gene sets

Figure 14: GO Biological Processes Gene Set Collection Enrichment Map with ‘Very conservative’ parameters
only showing blue nodes.
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Figure 15: GO Biological Processes Gene Set Collection Enrichment Map with ‘Very conservative’ parameters
only showing red nodes.
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IV. Discussion
A. Results for GLDS-103
1) Reproducibility of Nextflow
The results produced from NRCP in comparison to NASA is almost identical. Despite
differences in number of genes when filtered by p-value, different versions of software and
databases would produce different results and the objective of this project is to possibly offer
new insights in GLDS-103. The PCA plots, depicted in Figure 10 is a case of reproducibility since
the PCA plot produced from NRCP is near identical to the PCA plot from NRCP. However,
identical PCA plots could also mean that unique genes found in NRCP did not cause a change in
variance.
2) NRCP and Resource Requirements
CoS-HPC served as an incredible asset in this project due to its large memory capacity and
its processing power. About 103 GB of raw data was downloaded from GeneLab to CoS-HPC
and processed. As shown in Table I, about 2 days was needed to produce 502.65 GB of data
with CPU hours clocking over 255 hours. Using a daily computer would take NRCP a lot longer
than shown. Trim Galore, STAR alignment, and Count alignment, took the longest to finish, with
Trim Galore averaging 136 minutes, STAR alignment averaging 241 minutes, and Count
alignment averaging 306 minutes. Speed up time in these tools would be beneficial for future
research/studies regarding spaceflight. For instance, the tool, fastp, does all preprocessing jobs
and at a faster speed than Cutadapt [59].

Figure 16: Plot of amount of time elapsed for each process
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3) Gene Set Analysis
The top three results for DAVID and GSEA Hallmark gene sets will be observed, with the
exception to the downregulated Hallmark gene sets. This fulfils the FDR cut-off for GSEA since all top
three gene sets produced from the Hallmark gene sets have an FDR q-value less than 0.05 (recommend
FDR cut-off by GSEA due to permutation by gene sets). It is important to note that FDR q-values for
myogenesis and inflammatory response are above the FDR q-value and it is quite possible that these
gene sets were not relevant for the Quadriceps muscle under microgravity reasons. This is mainly for
curiosity reasons and the chance for the gene sets for myogenesis and inflammatory response are, in
fact, false positives.

a) DAVID gene annotation clusters
Circadian rhythm plays an important role in muscle atrophy. By definition, Circadian
rhythm is a human’s regular physiological activities, regulated by diet, exercise, sleep,
endocrine activity, and metabolism [60]. Major factors that affect circadian rhythm are, aging,
diet, lack of exercise, external light sources, and disease, all of which induce muscle atrophy
[61]–[64]. A recent study discovered a connection between circadian rhythm and skeletal
muscle atrophy, of which Choi et al. discovered irregular working schedules increase skeletal
muscle atrophy [65]. A mechanism that controls regulation of the musculoskeletal system is
called the molecular clock, a series of interconnected transcriptional-translational feedback
loops [66]. Further investigation of the molecular clock mechanism is shown to be present
within all cells within the body, including both skeletal muscle and bone [67]–[70]. However,
there seems to be little understanding of bone cell clock disruption and this is evident as
Schroder et al. is the only study to describe the systematic effects of skeletal muscle rhythms to
maintenance of bone [71].
Annotation Cluster 2 indicates that repressor, transcription regulation, and dna-binding
are disrupted in microgravity. However, nothing clear sticks out on what exactly causes
disruption in this annotation cluster. A deep dive on what genes is prevalent in all these
keywords would open insights. As shown in Figure 17, Mafb, Nr1d1, Klf11, Nfil3, Zkscan17, and
Nr1d2, are all genes prevalent in the annotated terms for Cluster 2. Mafb can either be a
transcriptional activator or repressor and loss of this gene function results in a different type of
muscle around the eye [72], [73]. Nr1d1, or commonly named in articles, Rev-erbA-alpha, is an
interesting gene, as it is a transcriptional repressor that coordinates circadian rhythm and
metabolic pathways [72], [74]. Klf11 is a suppressor of endothelial cell inflammatory activation
[75]. Nfil3 is an important transcription factor for the development of natural killer cells and
type 1 innate lymphoid cells [76, p. 3]. Not much is known about Zkscan17 (also called Nizp1)
besides being a protein that interacts with NSD1 [77, p. 1]. Nr1d2 is known to be a repressor for
circadian rhythm genes [78, p. 2]. These genes have shown to regulate transcription in some
pathway, system, or mechanism, some of which to be repressors of the circadian rhythm.
Metal-binding, zinc, and zinc finger are terms clustered in Annotation Cluster 3. Looking
at the genes that were connected to this cluster, Zinc and ring finger 2 and 3 (Znrf2, Znrf3) and
ring finger protein 31, 114, 122, 128, 139, and 167 (RNF31, RNF114, RNF122, RNF128, RNf139,
RNF167) were noticeable and prevalent across all cluster terms. It is possible that there is some
connection between microgravity and zinc and ring finger genes. Zinc is important for every life
on Earth, in fact, one out of ten human proteins are zinc related [79]. The ring domain
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composition of the zinc finger can variate, providing different molecular function. CXXC5 and
EGR3 are zinc-finger proteins that regulate skeletal myogenesis [80]. Lynch et al. found that zinc
finger protein 593 (Zfp593), a protein-coding gene, is expressed in skeletal muscle and gets
upregulated during skeletal muscle atrophy [81]. Unfortunately, the 3 aforementioned genes
are not found in Cluster 3 but could be relevant in other skeletal muscle in the RR project.

Figure 17: Genes that are prevalent in all annotated terms of cluster 2

b) Investigation of upregulated hallmark gene sets
GSEA investigates the whole gene list, accounting for genes that have smaller expression
values compared to significant genes of the whole gene list. This allows the user to see the gene
list as a whole and not by a gene-by-gene basis. The hallmark gene set collection is used as it is
an excellent gene set collection as a starting point of investigation.
In the Rodent Research project, NASA found that TGF-β1 is the most common regulator in
microgravity and space radiation conditions [7]. TGF-β1 is an important cytokine and can cause
fibrosis. Table III showcases the gene sets that are upregulated, or in this case, gene sets that
are upregulated in FLT mice. Interferon gamma is known to be a TGF-β1 inhibitor, and because
of this, interferon gamma is an antifibrosis agent [82], [83]. Cholesterol is stored in the T-tubule
membranes in skeletal muscle tissue [11]. The cholesterol uptake to the skeletal muscle leads
enrichment of muscle fiber membrane (sarcolemma) [84]. Cholesterol homeostasis
upregulation is reasonable in microgravity conditions, as the skeletal muscle tries to maintain
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its composition through cholesterol homeostasis by absorbing more cholesterol. Hedgehog
signaling is upregulated in spaceflight, and a relevant gene, sonic hedgehog (SHH) is prevalent
in significant gene sets as shown in Table V. Caradu et al. investigated the effects of SHH on
ischaemic (restriction of blood flow to tissues) mice and found that ectopic SHH promoted
ischaemia-induced angiogenesis [85].

c) Investigation of the downregulated hallmark gene sets
Table IV shows that the gene sets, MYC targets versions 2 and 1, are downregulated in FLT
mice. MsigDB describes these two gene set collection as genes regulated by MYC. MYC is a
proto-oncogene, thus, downregulation of MYC results in cell proliferation and cause
inducement of cell apoptosis [86]. Referring to Table V, none of these genes are listed in the
MYC target version 2 and 1 gene set. Reactive oxidative species (ROS) are produced as a byproduct of cellular metabolic pathways [87]. Contraction of the skeletal muscle tissue produces
ROS, where low levels is required for normal skeletal muscle force and high levels causes
contractile dysfunction and fatigue [88]. This may suggest mice can produce less ROS under
microgravity conditions. Uchida et al. studied the effects of microgravity on L6 myotubes rats
and found increased ROS production signals the (Egr)1/2-Cbl-b signaling pathway, known to
contribute to muscle volume lost [20]. This study is contradictory to the findings of GSEA since
FLT mice experience downregulation of the ROS pathway, but an explanation could be the
mice’ condition in the experiment. The downregulation of myogenesis and inflammatory
response proves previous studies of spaceflight induces skeletal muscle atrophy [16]–[18].
There has been a study regarding astronauts being exposed to microgravity had their stressresponse genes be suppressed, including genes that are important to DNA repair, oxidative
stress, and protein folding [89].
d) Insights to GO biological processes terms through the C5 GO BP subset
Figure 13, 15, and 16 were figures created by the EnrichmentMap app, with Cytoscape as
the platform. Figure 13 was manually annotated based on the GO BP term while Figure 14 and
16 were automatically annotated by AutoAnnotation and WordCloud. The different parameters
suggest that there are not a lot of significant gene sets. Running EnrichmentMap with
‘Moderately conservative’ parameters excluded 237 gene sets, while running with ‘Very
permissive’ parameters included the 237 gene sets. Interleukin 1 production cluster in Figure 13
have gene sets involving negative regulation of interleukin and production of interleukin-1 beta.
Interleukin-1 beta is a proinflammatory cytokine upregulated in Parkinson disease, a disease
linked to skeletal muscle atrophy [90], [91]. Interestingly, the same studies, have shown that
tumor necrosis factor, a gene like interleukin-1 beta, to be also upregulated in Parkinson
disease. In Figure 15, interleukin 1 production includes a gene set related to tumor necrosis
factor production; however, this gene set was excluded from the ‘Moderately conservative’
enrichment map due to having an FDR q-value of 0.2312. This shows that, despite gene sets
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being excluded, there is a chance for the gene set of not being a false positive. Future studies
would require limiting the number of gene sets to compare with in C5 GO BP subset in order to
increase the statistical power.

V. Conclusion
Results from analyzing GLDS-103 shows strong relations to the circadian rhythm and
skeletal muscle health. In addition, a possible relation of musculoskeletal system to the bone
system by the mechanism called the molecular clock. The results also shown cases of the zinc
finger protein and its variants being disrupted but also shows that the genes disrupted are
linked to circadian rhythm. NASA has found TGF-β1 to be present across the Research Rodent
project, and this project has shown an inhibitor to TGF-β1, the interferon gamma gene.
Additionally, this project has shown to validate other spaceflight research to skeletal muscle
atrophy. Enrichment maps of the C5 GO BP subset show insight to possible future BP studies. As
proven in this project, a gene set, that was excluded due to its high FDR q-value, was shown to
be important in a study regarding the Parkinson disease.
This project has shown the reproducibility of Nextflow implementation, showing almost
identical results to GeneLab. The greatest advantage of NRCP is that it can be rerun with
different parameters, such as ENSEMBL version specification, allowing the pipeline to be ran
with updated versions of the mouse genome and annotation. This was the case as GeneLab
used an older version of ENSEMBL and this project showed differences of results when filtering
genes to a p-value of less than 0.05. This project also highlights the importance of high memory
and high processing power systems, as almost 2 days were required to process the entire raw
data of GLDS-103. Quality checks of the raw data has shown no problems with the raw data and
alignment results indicate enough reads being uniquely mapped to the genome.
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